Follicular Lymphoma

Common Name(s)

Follicular Lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Follicular Lymphoma" returned 545 free, full-text research articles on human participants. First 3 results:

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
 

Author(s): Jason R Westin, Fuliang Chu, Min Zhang, Luis E Fayad, Larry W Kwak, Nathan Fowler, Jorge Romaguera, Fredrick Hagemeister, Michelle Fanale, Felipe Samaniego, Lei Feng, Veerabhadran Baladandayuthapani, Zhiqiang Wang, Wencai Ma, Yanli Gao, Michael Wallace, Luis M Vence, Laszlo Radvanyi, Tariq Muzzafar, Rinat Rotem-Yehudar, R Eric Davis, Sattva S Neelapu

Journal: Lancet Oncol.. 2014 Jan;15(1):69-77.

 

Endogenous or iatrogenic antitumour immune responses can improve the course of follicular lymphoma, but might be diminished by immune checkpoints in the tumour microenvironment. These checkpoints might include effects of programmed cell death 1 (PD1), a co-inhibitory receptor that ...

Last Updated: 3 Jan 2014

Go To URL
[Chinese guidelines for diagnosis and treatment of follicular lymphoma(2013)].
 

Author(s): ,

Journal: Zhonghua Xue Ye Xue Za Zhi. 2013 Sep;34(9):820-4.

 

Last Updated: 9 Oct 2013

Go To URL
Transplantation in follicular lymphoma: not "yes or no" but "whom and when".
 

Author(s): Georg Hess, Ralf Georg Meyer

Journal: Haematologica. 2013 Sep;98(9):1333-4.

 

Last Updated: 5 Sep 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Follicular Lymphoma" returned 54 free, full-text review articles on human participants. First 3 results:

Dissecting follicular lymphoma: high versus low risk.
 

Author(s): Sonali M Smith

Journal: Hematology Am Soc Hematol Educ Program. 2013 ;2013():561-7.

 

Progress in the management of follicular lymphoma (FL) has translated to improved outcomes, with most patients surviving a decade or more from the time of diagnosis. However, the disease remains quite heterogeneous and a substantial number of patients have more aggressive disease ...

Last Updated: 9 Dec 2013

Go To URL
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy.
 

Author(s): Madhav Desai, Kate J Newberry, Jorge Romaguera, Liang Zhang, Zhishuo Ou, Michael Wang

Journal:

 

Lenalidomide is an immunomodulatory agent which has been approved for multiple myeloma. Lenalidomide is also effective in and tolerated well by patients with follicular lymphoma, diffuse large B-cell lymphoma, and transformed large cell lymphoma. This review summarizes the results ...

Last Updated: 6 Aug 2013

Go To URL
Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature.
 

Author(s): Brady E Beltran, Pilar Quiñones, Domingo Morales, Jose C Alva, Roberto N Miranda, Gary Lu, Bijal D Shah, Eduardo M Sotomayor, Jorge J Castillo

Journal: Leuk. Res.. 2013 Sep;37(9):1116-9.

 

Follicular lymphoma (FL) is a prevalent type of non-Hodgkin lymphoma in the United States and Europe. Although, FL typically presents with nodal involvement, extranodal sites are less common, and leukemic phase at diagnosis is rare. There is mounting evidence that leukemic presentation ...

Last Updated: 2 Aug 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
 

Status: Recruiting

Condition Summary: Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma

 

Last Updated: 27 Jun 2014

Go to URL
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
 

Status: Recruiting

Condition Summary: Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma

 

Last Updated: 9 Jul 2014

Go to URL
Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
 

Status: Recruiting

Condition Summary: Follicular Lymphoma; Follicular Non-Hodgkin´s Lymphoma; Autologous Effector Lymphocytes

 

Last Updated: 5 Aug 2013

Go to URL